Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review

被引：3
|
作者：
Tarafdar, Nawar [1 ]
Sachdeva, Muskaan [2 ]
Savinova, Iryna [3 ]
Lytvyn, Yuliya [2 ]
Maliyar, Khalad [2 ]
Georgakopoulos, Jorge R. [2 ]
Mufti, Asfandyar [2 ]
Yeung, Jensen [2 ,4 ]
机构：
[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Womens Coll Hosp, Div Dermatol, 76 Grenville St, 5th Floor, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 90卷 / 02期
关键词：
atezolizumab; camrelizumab; cemiplimab; durvalumab; immune checkpoint inhibitor; immunotherapy; ipilimumab; nivolumab; pembrolizumab; psoriasis; systematic review;
D O I：
10.1016/j.jaad.2023.09.070
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：392 / 395
页数：4
相关论文
共 50 条
  • [41] The Efficacy and Safety of Solid Tumors Combination Therapy with Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S928 - S929
  • [42] Adverse Event Reporting Quality in Cancer Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy: A Systematic Review
    Wang, Yuhong
    Chen, Chen
    Du, Wei
    Zhou, Yixin
    He, Lina
    Hong, Shaodong
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis
    Park, Hyo Jung
    Kim, Kyung Won
    Pyo, Junhee
    Suh, Chong Hyun
    Yoon, Shinkyo
    Hatabu, Hiroto
    Nishino, Mizuki
    RADIOLOGY, 2020, 297 (01) : 87 - 96
  • [44] The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis
    Peng, Min
    Li, Xing
    Lei, Gu
    Weng, Yi Ming
    Hu, Meng Xue
    Song, Qi Bin
    ONCOTARGETS AND THERAPY, 2018, 11 : 7369 - 7383
  • [45] Immune thrombocytopenia after immune checkpoint inhibitor therapy
    Amanam, Idoroenyi
    Gupta, Rohan
    Pullarkat, Vinod
    Mei, Matthew
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 677 - 681
  • [46] Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic review
    Tan, Sean
    Sivakumar, Seiyon
    Segelov, Eva
    Nicholls, Stephen J.
    Nelson, J.
    CANCER EPIDEMIOLOGY, 2023, 83
  • [47] Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review
    Pierrard, J.
    Seront, E.
    CURRENT ONCOLOGY, 2019, 26 (06) : 395 - 403
  • [48] Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review
    Collins, Michael
    Soularue, Emilie
    Marthey, Lysiane
    Carbonnel, Franck
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) : 1393 - +
  • [49] The effect of gastrointestinal microbiome supplementation on immune checkpoint inhibitor immunotherapy: a systematic review
    Anjali Bhatt
    Alyson Haslam
    Vinay Prasad
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7355 - 7362
  • [50] The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge-A Systematic Review
    Perdyan, Adrian
    Sobocki, Bartosz Kamil
    Balihodzic, Amar
    Dabrowska, Anna
    Kacperczyk, Justyna
    Rutkowski, Jacek
    CANCERS, 2023, 15 (13)
12345